Unum Therapeutics Inc (UMRX) Stock News
NASDAQ:UMRX - Nasdaq -
UMRX Latest News, Press Relases and Analysis
Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
Cogent Biosciences is focused on the design of rational precision therapies to improve the lives of patients
Benzinga's Top Upgrades, Downgrades For October 2, 2020
Upgrades According to Evercore ISI Group, the prior rating for Splunk Inc (NASDAQ: SPLK) was changed from In-Line to Outperform. Splunk earned $0.33 in the second quarter,...
Is Unum Therapeutics (UMRX) Stock Outpacing Its Medical Peers This Year?
Is (UMRX) Outperforming Other Medical Stocks This Year?
AMRN, VXRT, HOME and GOGO among midday movers
Gainers: Corcept Therapeutics (NASDAQ:CORT) +35%.Vera Bradley (NASDAQ:VRA) +29%.NanoViricides (NYSEMKT:NNVC) +27%.Gogo (NASDAQ:GOGO) +25%.TSR (NASDAQ:TSRI) +24%.Flying Eagle Acquisition (NYSE:FEAC) +23%.SmileDirectClub (NASDAQ:SDC) +19%.Vaxart (NASDAQ:VXRT) +18%.Clearfield (NASDAQ:CLFD) +16%.Lazydays (NASDAQ:LAZY) +15%.Losers: Amarin (NASDAQ:AMRN) -28%.At Home Group (NYSE:HOME) -26%.Jiayin (NASDAQ:JFIN) -24%.ADiTx Therapeutics (NASDAQ:ADTX) -18%.GSX Techedu (NYSE:GSX) -17%.Aptorum Group (NASDAQ:APM) -17%.Unum Therapeutics (NASDAQ:UMRX) -15%.iClick Interactive Asia (NASDAQ:ICLK) -14%.AutoWeb (NASDAQ:AUTO) -14%.China HGS Real Estate (NASDAQ:HGSH) -13%.
56 Biggest Movers From Yesterday
Gainers Jounce Therapeutics, Inc. (NASDAQ: JNCE) shares surged 55.6% to close at $7.53 on Tuesday. Gilead Sciences and Jounce Therapeutics disclosed an exclusive license...
Unum Therapeutics' BOXR CAR-T platform and products rights acquired by SOTIO (NASDAQ:UMRX)
Unum Therapeutics' (UMRX -0.3%) BOXR cell therapy platform and BOXR lead programs, to develop novel T cell therapies for the treatment of solid tumors, were acquired by SOTIO, a clinical stage immuno-oncology company owned by PPF Group.The rights were acquired for $11.5M, including $8.1M upfront and potential $3.4M in milestones.The lead program,BOXR1030, is expected to initiate first clinical studies in 2021.SOTIO will build on Unum's R&D data, its team and a portion of its laboratory and manufacturing facility to create an R&D Center of Excellence for T cell therapies in Cambridge, MA.Unum's former CTO Geoff Hodge will join SOTIO to lead BOXR development team and all R&D of the next generation T cell therapies.
Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO
Transaction focused on the BOXR technology including lead program BOXR1030
Is Unum Therapeutics (UMRX) Stock Outpacing Its Medical Peers This Year?
Is (UMRX) Outperforming Other Medical Stocks This Year?
Venrock Healthcare Capital Partners acquires 0.451M shares of Unum Therapeutics (NASDAQ:UMRX)
Venrock Healthcare Capital Partners discloses the purchase 0.451M shares of Unum Therapeutics (NASDAQ:UMRX) between Aug. 14 and Aug.
TGT, NAK among premarket gainers
Momenta Pharmaceuticals (NASDAQ:MNTA) +69% on J&J acquisition.Hudson (NYSE:HUD) +49% on take over offer of $7.70/share from its controlling shareholder.LightInTheBox Holding (NYSE:LITB) +38% on Q2 results.Teligent (NASDAQ:TLGT) +36% on Q2 results.Immunovant (NASDAQ:IMVT) +20%.SilverSun Technologies (NASDAQ:SSNT) +12%.Accelerate Diagnostics (NASDAQ:AXDX) +10% on FDA emergency use nod for COVID-19 test.Energous (NASDAQ:WATT) +9% on strategic partnership with Xentris Wireless.Precision BioSciences (NASDAQ:DTIL) +9% as CAR-T therapy Fast Track'd for type of blood cancer.Target (NYSE:TGT) +9% on Q2 results.TRACON Pharmaceuticals (NASDAQ:TCON) +9%.Unum Therapeutics (NASDAQ:UMRX) +8%.Banco Bradesco S.A.
Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates
Completed acquisition of Kiq, including lead clinical-stage compound PLX9486, a potent and selective KIT D816V inhibitor
The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics
The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics
Allogene's (ALLO) Q2 Loss Widens Y/Y, Pipeline Progresses
Allogene (ALLO) reports no revenues for the second quarter of 2020.
Sarepta (SRPT) Q2 Loss Widens Y/Y, Revenues Beat Estimates
Sarepta (SRPT) Q2 revenues increase year over year.
Arena Pharmaceuticals (ARNA) Q2 Loss Narrower Than Expected
Arena Pharmaceuticals (ARNA) beats bottom-line estimates for the second quarter of 2020. Clinical progress remains on track amid COVID-19 pandemic.
Nasdaq Tops 11,000: 5 Best Stocks With Room for More Upside
On Aug 6, the Nasdaq Composite Index topped the milestone of 11,000. The tech-heavy laden completed its 1000-point journey in 40 trading days, representing the fastest ever rise in 20 years.
BioDelivery (BDSI) Q2 Earnings Miss, Revenues Beat, Stock Up
BioDelivery's (BDSI) strong Belubca sales drive the top line. Symproic further boosts revenues. Stock up.
Jazz Pharma (JAZZ) Beats on Q2 Earnings & Sales, Raises View
Jazz Pharmaceuticals (JAZZ) reports better-than-expected second-quarter 2020 earnings and revenues. It raises its guidance for 2020. Shares rise.
Amarin (AMRN) Beats on Q2 Earnings, Focuses on Europe
Amarin's (AMRN) revenue growth in the second quarter is attributable to continued demand for its cardiovascular drug, Vascepa.
Is Unum Therapeutics (UMRX) Outperforming Other Medical Stocks This Year?
Is (UMRX) Outperforming Other Medical Stocks This Year?
Unum Therapeutics Inc. (UMRX) Outpaces Stock Market Gains: What You Should Know
Unum Therapeutics Inc. (UMRX) closed the most recent trading day at $2.74, moving +1.86% from the previous trading session.
Best & Worst Performing Small Cap Stocks for July 17, 2020
VRNA – VRNA leads the way today as the best performing small cap stock, closing up 115.64%.
Dynavax Signs a Pact to Develop Universal Influenza Vaccine
Dynavax (DVAX) inks a deal with Mount Sinai to develop a universal influenza vaccine candidate using its CpG 1018 adjuvant. The development is funded under a contract win from NIAID.
Top Ranked Momentum Stocks to Buy for July 17th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th
NFLX, CEQP, PHAS and JRJC among after-hours movers
Gainers: HMHC +13.6%. FRGI +11.7%. CEQP +9%.
Nabriva Soars on Agreement With Merck to Distribute Sivextro
Nabriva (NBRV) signs a contract with the units of Merck for selling and distributing the latter's antibiotic Sivextro in the United States. Shares rise in pre-market trading.
Axsome Focuses on Filling NDAs for Two CNS Candidates in 2020
Axsome's (AXSM) CNS pipeline candidates are advancing well. NDAs for AXS-05 to address MDD and AXS-07 as an acute treatment of migraine will be filed in Q4. Lack of a marketed product is a concern.
Best & Worst Performing Small Cap Stocks for July 14, 2020
PRCP – PRCP leads the way today as the best performing small cap stock, closing up 111.73%.